Cargando…

Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions

Detalles Bibliográficos
Autores principales: Schwitzguebel, Adrien J, Kolo, Frank C., Tirefort, Jérome, Kourhani, Abed, Nowak, Alexandra, Gremeaux, Vincent, Saffarini, Mo, Lädermann, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543796/
http://dx.doi.org/10.1177/2325967119S00210
_version_ 1783423145282109440
author Schwitzguebel, Adrien J
Kolo, Frank C.
Tirefort, Jérome
Kourhani, Abed
Nowak, Alexandra
Gremeaux, Vincent
Saffarini, Mo
Lädermann, Alexandre
author_facet Schwitzguebel, Adrien J
Kolo, Frank C.
Tirefort, Jérome
Kourhani, Abed
Nowak, Alexandra
Gremeaux, Vincent
Saffarini, Mo
Lädermann, Alexandre
author_sort Schwitzguebel, Adrien J
collection PubMed
description
format Online
Article
Text
id pubmed-6543796
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-65437962019-06-12 Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions Schwitzguebel, Adrien J Kolo, Frank C. Tirefort, Jérome Kourhani, Abed Nowak, Alexandra Gremeaux, Vincent Saffarini, Mo Lädermann, Alexandre Orthop J Sports Med Article SAGE Publications 2019-05-30 /pmc/articles/PMC6543796/ http://dx.doi.org/10.1177/2325967119S00210 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For article reuse guidelines, please visit SAGE’s website at http://www.sagepub.com/journals-permissions.
spellingShingle Article
Schwitzguebel, Adrien J
Kolo, Frank C.
Tirefort, Jérome
Kourhani, Abed
Nowak, Alexandra
Gremeaux, Vincent
Saffarini, Mo
Lädermann, Alexandre
Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions
title Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions
title_full Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions
title_fullStr Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions
title_full_unstemmed Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions
title_short Efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: A randomized, double-blinded, controlled trial: PRP for Interstitial Supraspinatus Lesions
title_sort efficacy of platelet-rich plasma for the treatment of interstitial supraspinatus lesions: a randomized, double-blinded, controlled trial: prp for interstitial supraspinatus lesions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543796/
http://dx.doi.org/10.1177/2325967119S00210
work_keys_str_mv AT schwitzguebeladrienj efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions
AT kolofrankc efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions
AT tirefortjerome efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions
AT kourhaniabed efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions
AT nowakalexandra efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions
AT gremeauxvincent efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions
AT saffarinimo efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions
AT ladermannalexandre efficacyofplateletrichplasmaforthetreatmentofinterstitialsupraspinatuslesionsarandomizeddoubleblindedcontrolledtrialprpforinterstitialsupraspinatuslesions